280 related articles for article (PubMed ID: 26911203)
21. A qualitative study of perceived risk for HIV transmission among police officers in Dar es Salaam, Tanzania.
Tarimo EA; Kohi TW; Bakari M; Kulane A
BMC Public Health; 2013 Aug; 13():785. PubMed ID: 23984994
[TBL] [Abstract][Full Text] [Related]
22. Characteristics and geographic distribution of HIV-positive women diagnosed with cervical cancer in Dar es Salaam, Tanzania.
Lovgren K; Soliman AS; Ngoma T; Kahesa C; Meza J
Int J STD AIDS; 2016 Oct; 27(12):1049-1056. PubMed ID: 26464500
[TBL] [Abstract][Full Text] [Related]
23. Motivations for participating in an HIV vaccine efficacy trial.
Colfax G; Buchbinder S; Vamshidar G; Celum C; McKirnan D; Neidig J; Koblin B; Gurwith M; Bartholow B
J Acquir Immune Defic Syndr; 2005 Jul; 39(3):359-64. PubMed ID: 15980699
[TBL] [Abstract][Full Text] [Related]
24. Key considerations in scaling up male circumcision in Tanzania: views of the urban residents in Tanzania.
Francis JM; Kakoko D; Tarimo EA; Munseri P; Bakari M; Sandstrom E
Tanzan J Health Res; 2012 Jan; 14(1):61-7. PubMed ID: 26591748
[TBL] [Abstract][Full Text] [Related]
25. Motivation, recruitment, and screening of volunteers for a phase I/II HIV preventive vaccine trial in Thailand.
Jenkins RA; Chinaworapong S; Morgan PA; Ruangyuttikarn C; Sontirat A; Chiu J; Michael RA; Nitayaphan S; Khamboonruang C
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):171-7. PubMed ID: 9637582
[TBL] [Abstract][Full Text] [Related]
26. Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
Nyaoke BA; Mutua GN; Sajabi R; Nyasani D; Mureithi MW; Anzala OA
PLoS One; 2017; 12(9):e0183788. PubMed ID: 28880880
[TBL] [Abstract][Full Text] [Related]
27. Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda.
Asiki G; Abaasa A; Ruzagira E; Kibengo F; Bahemuka U; Mulondo J; Seeley J; Bekker LG; Delany S; Kaleebu P; Kamali A
Vaccine; 2013 Oct; 31(44):5055-61. PubMed ID: 24021306
[TBL] [Abstract][Full Text] [Related]
28. Young men who have sex with men's awareness, acceptability, and willingness to participate in HIV vaccine trials: Results from a nationwide online pilot study.
Connochie D; Tingler RC; Bauermeister JA
Vaccine; 2019 Oct; 37(43):6494-6499. PubMed ID: 31522806
[TBL] [Abstract][Full Text] [Related]
29. Altruism, Scepticism, and collective decision-making in foreign-born U.S. residents in a tuberculosis vaccine trial.
Craig SR; Lahey T; Dixit A; Fordham von Reyn C
BMC Public Health; 2018 Apr; 18(1):535. PubMed ID: 29685114
[TBL] [Abstract][Full Text] [Related]
30. Participants' characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa.
Hanass-Hancock J; Carpenter B; Reddy T; Nzuza A; Gaffoor Z; Goga A; Andrasik M
Trials; 2021 Dec; 22(1):897. PubMed ID: 34895272
[TBL] [Abstract][Full Text] [Related]
31. What motivates or demotivates injecting drug users to participate in hypothetical HIV vaccine efficacy trials? A qualitative study from urban Tanzania.
Iseselo MK; Tarimo EA; Sandstrom E; Kulane A
East Afr Health Res J; 2020; 4(2):128-139. PubMed ID: 34308230
[TBL] [Abstract][Full Text] [Related]
32. Socio-economic and demographic factors associated with prevalence of HIV infection among pregnant women in Dar es Salaam, Tanzania.
Msamanga G; Fawzi W; Hertzmark E; McGrath N; Kapiga S; Kagoma C; Spiegelman D; Hunter D
East Afr Med J; 2006 Jun; 83(6):311-21. PubMed ID: 16989376
[TBL] [Abstract][Full Text] [Related]
33. Incentives and disincentives to participate in prophylactic HIV vaccine research.
Jenkins RA; Temoshok LR; Virochsiri K
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 May; 9(1):36-42. PubMed ID: 7712233
[TBL] [Abstract][Full Text] [Related]
34. Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies.
Dhalla S; Poole G
AIDS Care; 2011 Nov; 23(11):1430-47. PubMed ID: 21722022
[TBL] [Abstract][Full Text] [Related]
35. A pilot study on willingness to participate in future preventive HIV vaccine trials.
Suhadev M; Nyamathi AM; Swaminathan S; Venkatesan P; Raja Sakthivel M; Shenbagavalli R; Suresh A; Fahey JL
Indian J Med Res; 2006 Dec; 124(6):631-40. PubMed ID: 17287550
[TBL] [Abstract][Full Text] [Related]
36. Perceptions of a community sample about participation in future HIV vaccine trials in south India.
Nyamathi AM; Suhadev M; Swaminathan S; Fahey JL
AIDS Behav; 2007 Jul; 11(4):619-27. PubMed ID: 17016758
[TBL] [Abstract][Full Text] [Related]
37. Altruism motivates participation in a therapeutic HIV vaccine trial (CTN 173).
Balfour L; Corace K; Tasca GA; Tremblay C; Routy JP; Angel JB
AIDS Care; 2010 Nov; 22(11):1403-9. PubMed ID: 20936540
[TBL] [Abstract][Full Text] [Related]
38. Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya.
Nyasani DK; Mutua GN; Sajabi RM; Ng'ang'a JW; Gachie JN; Maina AM; Lusike LL; Anzala AO; Price MA; Manyonyi GO
PLoS One; 2018; 13(11):e0206656. PubMed ID: 30388145
[TBL] [Abstract][Full Text] [Related]
39. Dental students' knowledge of AIDS and HIV infection in Helsinki, Finland, and in Dar es Salaam, Tanzania.
Ranta K; Tuominen R
Acta Odontol Scand; 1991 Apr; 49(2):79-83. PubMed ID: 2053432
[TBL] [Abstract][Full Text] [Related]
40. A qualitative evaluation of volunteers' experiences in a phase I/II HIV vaccine trial in Tanzania.
Tarimo EA; Thorson A; Kohi TW; Bakari M; Sandstrom E; Mhalu F; Kulane A
BMC Infect Dis; 2011 Oct; 11():283. PubMed ID: 22023776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
